IP Library Assignment 073076/0992
Patent Assignment
Reel/Frame 073076/0992

Request for Assignee Address Update

Recorded: 2025-10-14 Pages: 3
Assignor
IPSEN PHARMA S.A.S.
Executed: 2025-07-25
Assignee
IPSEN PHARMA S.A.S.
70 RUE BALARD, PARIS, 75015, FRANCE
Covered Properties (27)
Melanocortin Receptor Ligands
Patent: 8,039,435 →
Application: 11/988,533 →
Publication: US 2010/0279922
Method of Treating Osteoporosis Comprising Administration of Pthrp Analog
Patent: 7,803,770 →
Application: 12/151,975 →
Publication: US 2009/0227498
A Stable Composition Comprising a Pthrp Analogue
Patent: 8,148,333 →
Application: 12/311,418 →
Publication: US 2010/0029556
Sustained release formulations comprising very low molecular weight polymers
Patent: 9,724,397 →
Application: 12/447,431 →
Publication: US 2010/0209384
Melanocortin Receptor Ligands Modified with Hydantoin
Patent: 8,563,000 →
Application: 12/602,010 →
Publication: US 2010/0184646
Use of Melanocortins to Treat Insulin Sensitivity
Patent: 9,155,777 →
Application: 12/740,917 →
Publication: US 2010/0311647
PROTEIN DELIVERY SYSTEM TO GENERATE PLURIPOTENT STEM (iPS) CELLS OR TISSUE SPECIFIC CELLS
Patent: 8,420,352 →
Application: 12/870,782 →
Publication: US 2011/0053244
Therapeutic Use of at Least One Botulinum Neurotoxin in the Treatment of Pain Associated with Diabetic Neuropathy
Patent: 8,784,841 →
Application: 12/989,608 →
Publication: US 2011/0038893
Melanocortin Receptor Ligands
Patent: 9,458,195 →
Application: 13/074,565 →
Publication: US 2011/0183886
N-End Rule Protease Activity Indication Methods and Uses Thereof
Patent: 8,940,482 →
Application: 13/159,284 →
Publication: US 2015/0010931
Imidazolidine-2,4-Dione Derivatives, and Use Thereof as a Cancer Drug
Patent: 8,710,091 →
Application: 13/264,971 →
Publication: US 2012/0083514
Method of Drug Delivery for Bone Anabolic Protein
Patent: 8,748,382 →
Application: 13/438,086 →
Publication: US 2013/0157955
Pharmaceutical Compositions of Melanocortin Receptor Ligands
Patent: 9,314,509 →
Application: 13/508,777 →
Publication: US 2012/0225816
Process for the Preparation of Pharmaceutical Compositions for the Sustained Release of Somatostatin Analogs
Patent: 9,352,012 →
Application: 13/522,297 →
Publication: US 2013/0079282
PROTEIN DELIVERY SYSTEM TO GENERATE INDUCED PLURIPOTENT STEM (iPS) CELLS OR TISSUE-SPECIFIC CELLS
Patent: 9,102,921 →
Application: 13/862,087 →
Publication: US 2013/0288374
Melanocortin Receptor Ligands Modified with Hydantoin
Patent: 9,296,783 →
Application: 14/024,961 →
Publication: US 2014/0011730
System for the Assessment of Protease Activity
Application: 14/026,014 →
Publication: US 2014/0017697
Sustained-Release Composition Containing Peptides as Active Ingredient
Patent: 9,415,012 →
Application: 14/126,365 →
Publication: US 2014/0127303
Therapeutic Use of at Least One Botulinum Neurotoxin in the Treatment of pain associated with diabetic neuropathy
Patent: 9,259,458 →
Application: 14/174,911 →
Publication: US 2014/0154781
N-End Rule Protease Activity Indication Methods and Uses Thereof
Patent: 9,624,529 →
Application: 14/606,352 →
Publication: US 2015/0329896
Use of Melanocortins to Treat Insulin Sensitivity
Patent: 9,439,943 →
Application: 14/844,128 →
Publication: US 2015/0366934
Pharmaceutical Composition for a Sustained Release of Lanreotide
Application: 14/903,010 →
Publication: US 2016/0151447
Melanocortin Receptor Ligands Modified with Hydantoin
Patent: 9,758,549 →
Application: 15/055,873 →
Publication: US 2016/0176925
Process for the Preparation of Pharmaceutical Compositions for the Sustained Release of Somatostatin Analogs
Application: 15/139,533 →
Publication: US 2016/0339075
Use of Melanocortins to Treat Insulin Sensitivity
Patent: 9,827,286 →
Application: 15/242,866 →
Publication: US 2016/0354429
Melanocortin Receptor Ligands
Patent: 9,850,280 →
Application: 15/587,426 →
Publication: US 2017/0240595
Method of Treating Osteoporosis Comprising Administration of Pthrp Analog
Patent: 49,444 →
Application: 17/133,968 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 9, 2008
From: BIOMEASURE, INCORPORATED
To: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S.
Reel/Frame 021656/0629 →
Assignment of Assignor's Interest Oct 9, 2008
From: MOREAU, JACQUES-PIERRE; DONG, ZHENG XIN
To: BIOMEASURE, INCORPORATED
Reel/Frame 021656/0632 →
Assignment of Assignor's Interest Apr 30, 2009
From: CHERIF-CHEIKH, ROLAND; DE SOUSA DELGADO, ANNE-PAULA; LACOMBE, FREDERIC; LACHAMP, LAURENCE
To: IPSEN PHARMA S.A.S
Reel/Frame 022621/0418 →
Change of Name Jun 15, 2009
From: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES
To: IPSEN PHARMA S.A.S.
Reel/Frame 022826/0976 →
Assignment of Assignor's Interest Jul 8, 2009
From: HENDERSON, BART; LYTTLE, C. RICHARD
To: RADIUS HEALTH, INC.
Reel/Frame 022929/0376 →
Assignment of Assignor's Interest Sep 10, 2009
From: DEY, MICHAEL J.; RIGAUD, BENEDICTE; MONDOLY, NATHALIE
To: IPSEN PHARMA S.A.S.
Reel/Frame 023212/0024 →
Assignment of Assignor's Interest Jan 8, 2010
From: DONG, ZHENG XIN; DEOLIVEIRA, DANIEL B.; COMSTOCK, JEANNE MARY
To: BIOMEASURE, INCORPORATED
Reel/Frame 023756/0165 →
Assignment of Assignor's Interest Jan 12, 2010
From: BIOMEASURE, INCORPORATED
To: IPSEN PHARMA S.A.S.
Reel/Frame 023764/0802 →
Assignment of Assignor's Interest May 26, 2010
From: BUTLER, ANDREW A.
To: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE
Reel/Frame 024442/0161 →
Assignment of Assignor's Interest Jun 8, 2010
From: HALEM, HEATHER A.; CULLER, MICHAEL DEWITT
To: BIOMEASURE, INCORPORATED
Reel/Frame 024499/0569 →
Assignment of Assignor's Interest Jun 8, 2010
From: BIOMEASURE, INCORPORATED
To: IPSEN PHARMA S.A.S.
Reel/Frame 024499/0928 →
Assignment of Assignor's Interest Oct 25, 2010
From: FAVRE, CHRISTINE; AUGUET, MICHEL; CHABRIER DE LASSAUNIERE, PIERRE-ETIENNE
To: IPSEN PHARMA S.A.S.
Reel/Frame 025190/0001 →
Assignment of Assignor's Interest Nov 24, 2010
From: OYLER, GEORGE A.; CHANG, YUNG-NIEN
To: SYNAPTIC RESEARCH, LLC
Reel/Frame 025420/0540 →
Change of Name Mar 31, 2011
From: S.C.R.A.S.
To: IPSEN PHARMA S.A.S.
Reel/Frame 026067/0176 →
Assignment of Assignor's Interest Dec 16, 2011
From: PREVOST, GREGOIRE; AUVIN, SERGE; LANCO, CHRISTOPHE; LIBERATORE, ANNE-MARIE
To: IPSEN PHARMA S.A.S.
Reel/Frame 027396/0349 →
Assignment of Assignor's Interest Dec 7, 2012
From: MONTES, MARTIN; LOUGHMAN, THOMAS CIARAN; ROUME, CHANTAL; CHERIF-CHEIKH, ROLAND
To: IPSEN PHARMA S.A.S.
Reel/Frame 029427/0922 →
Assignment of Assignor's Interest May 23, 2013
From: HENDERSON, BART; LYTTLE, C. RICHARD
To: RADIUS HEALTH, INC.
Reel/Frame 030475/0246 →
Assignment of Assignor's Interest May 23, 2013
From: DEY, MICHAEL J.; MONDOLY, NATHALIE; RIGAUD, BENEDICTE
To: IPSEN PHARMA S.A.S.
Reel/Frame 030475/0227 →
Assignment of Assignor's Interest Jan 21, 2014
From: DONG, ZHENG XIN; DEOLIVEIRA, DANIEL B.; COMSTOCK, JEANNE MARY
To: BIOMEASURE, INCORPORATED
Reel/Frame 032009/0267 →
Assignment of Assignor's Interest Jan 21, 2014
From: BIOMEASURE, INCORPORATED
To: IPSEN PHARMA S.A.S.
Reel/Frame 032009/0500 →
Change of Name Jan 24, 2014
From: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES
To: IPSEN PHARMA S.A.S.
Reel/Frame 032039/0537 →
Assignment of Assignor's Interest Jan 24, 2014
From: MOREAU, JACQUES PIERRE; DONG, ZHENG XIN
To: BIOMEASURE, INCORPORATED
Reel/Frame 032038/0644 →
Assignment of Assignor's Interest Jan 24, 2014
From: BIOMEASURE, INCORPORATED
To: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S.
Reel/Frame 032039/0243 →
Assignment of Assignor's Interest Dec 7, 2017
From: OYLER, GEORGE A.; TSAI, YIEN CHE
To: SYNAPTIC RESEARCH, LLC
Reel/Frame 044326/0554 →
Assignment of Assignor's Interest Dec 13, 2017
From: SYNAPTIC RESEARCH, LLC
To: IPSEN PHARMA S.A.S.
Reel/Frame 044377/0940 →